Useful Articles

Every so often we get a question asking why we don't "buy the dips" more when we are looking at p

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ossible stock plays and the answer is really simple. It's not "our" style. That isn't to say it's

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

wrong, or that you shouldn't do it, we just don't find it works as well for us.

Let me explain.

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

In the world of trading there are a zillion styles. Some ride momentum, some invest in fundamenta

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s, some are pure daytrades while some are swing traders. Some play the technicals, some play buyb

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

acks. Some play splits. Some play the market "versus" the bond pits. We tend to play sector stren

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

th and individual breakout/breakdowns.

There is a lot of money to be made on 3,5, and 8 day reve

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

rsal patterns. Watch the charts and you will see that stocks often reverse on those days, so buyi

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

g in and catching the bounce works for many people. Just because we don't focus on that strategy

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

doesn't make it wrong, it's just not "us". We like to look for break out or break down patterns,

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

nd try and correlate them to overall market directions.

Suppose you have a weak looking stock th

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

at is just barely hanging onto support.If the overall market puts in a huge day, chances are that

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

stock will not violate it's support and fall. But on the other hand, if you find that weak patter

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

n and then the market has a bad hair day, chances are pretty good that it will roll over and fall

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

pretty hard. So, we short it. On the long side the theory works the same way. Find a stock lookin

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

g to break out and couple it with a bounce or rising market. It will usually make it.

So, we don

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

t have anything against working reversals, buying dips, etc. It's simply not our style, and lets

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

face facts, some people do some things better than others. We aren't great at picking reversals,

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ut we are pretty good at breakout/breakdowns. If you find yourself getting good at picking revers

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

al plays, by all means go for it folks. In fact, shoot us a note and let us know how you're doing

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefularticles.org.ua/article/117830/usefularticles-Why-Not-Buy-the-Dips.html">Why Not Buy the Dips?</a>

BB link (for phorums):
[url=http://www.usefularticles.org.ua/article/117830/usefularticles-Why-Not-Buy-the-Dips.html]Why Not Buy the Dips?[/url]

You have been if you’re a business, non-profit or association manager whose public relations budget is focused largely on nifty brochures, column mentions and broadcast plugs. Especially without a wo...

Every day, people are becoming millionaires doing business over the Internet. You can be one of them. Once you find a market, or customers, who are able and willing to buy your product, you are on your way.

Debt consolidation tips are useful for availing basic suggestions so that paying off debts becomes an easier task. There are many experts who can offer you valuable suggestions. The article shows some basics before you go for debt consolidation.

Tags

Links

Useful Articles - Why Not Buy the Dips?

Related Articles: